Report overview
This report contains market size and forecasts of Lung Cancer Therapy in Global, including the following market information:
Global Lung Cancer Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Lung Cancer Therapy market was valued at 23730 million in 2021 and is projected to reach US$ 45650 million by 2028, at a CAGR of 9.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Radiation Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lung Cancer Therapy include GlaxoSmithKline, Menarini, Pfizer, Roche, Merck, AstraZeneca, Sanofi-Aventis, Eli Lilly and Company and Abbott, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Lung Cancer Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lung Cancer Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Lung Cancer Therapy Market Segment Percentages, by Type, 2021 (%)
Radiation Therapy
Chemotherapy
Targeted Therapies
Immunotherapy
Global Lung Cancer Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Lung Cancer Therapy Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Other
Global Lung Cancer Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Lung Cancer Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lung Cancer Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Lung Cancer Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Menarini
Pfizer
Roche
Merck
AstraZeneca
Sanofi-Aventis
Eli Lilly and Company
Abbott
Akebia Therapeutics
Agennix AG
